Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156260 · ClinicalTrials.gov registry record
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- 88
- Enrollment target
NCT00156260: Clinical Trial study, sponsored by University of Michigan Rogel Cancer Center.
NCT00156260 is a clinical trial that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00156260 was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- 88 participants
- Enrollment target
Study Summary
The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyze its biochemical composition, for investigational purposes only.
Interventions
- PROCEDURE Ductal lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-10 |
Why NCT00156260 stopped before completion
NCT00156260 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ductal lavage is the first listed.
NCT00156260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00156260 about?
NCT00156260 is a clinical study titled "Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage". The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyz...
What is the current status of trial NCT00156260?
This trial is currently terminated. The enrollment target is 88 participants. The study started on 2003-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00156260?
The interventions under investigation include: Ductal lavage (PROCEDURE).
Who is sponsoring clinical trial NCT00156260?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia